Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/1998
08/20/1998WO1998035660A1 Transdermal, oral and intravenous preparations of 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzoquinone
08/20/1998WO1998035658A2 The use of 2,3-dimethoxy-5-methyl-6-decaprenyl-1,4-benzoquinone
08/20/1998WO1998035656A1 Process for preparing solid pharmaceutical dosage forms
08/20/1998WO1998035655A2 Method for separating active substances in solid pharmaceutical preparations
08/20/1998WO1998035649A1 Sunscreen composition comprising a solid elastomeric organopolysiloxane
08/20/1998WO1998035554A2 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
08/20/1998WO1998027058A3 N-piperazin-1-ylphenyl-benzamide derivatives
08/20/1998WO1998022136A3 Stable lyophilized pharmaceutical substances from monoclonal or polyclonal antibodies
08/20/1998WO1998020880A3 11-Halo prostaglandins for the treatment of glaucoma or ocular hypertension
08/20/1998WO1998020146A3 Stabilized transient gene expression
08/20/1998WO1998017689A3 Il-12 gene expression and delivery systems and uses
08/20/1998WO1998017284A3 Inhibition of cap-independent protein synthesis and hiv-tar translation by heparin or heparin mimetics, and methods for gene therapy
08/20/1998WO1998014596A3 Disease associated protein tyrosine phosphatases
08/20/1998WO1998014215A3 Glycoconjugates as virus cell adhesion inhibitors
08/20/1998EP0880352A3 Stabilization of naloxonhydrochlorid
08/20/1998DE3790355C2 Prodn. of preparations of high gastric acid binding capacity
08/20/1998DE19706463A1 Neue Verwendung von Azolen New use of azoles
08/20/1998DE19706161A1 Verwendung von Cyaninen, Isocyaninen und Pseudoisocyaninen als Diuretika Use of cyanines, Isocyaninen and Pseudoisocyaninen as diuretics
08/20/1998DE19705963A1 Vernetzte Vinylpolymere mit Gallensäure-Adsorberwirkung Networked vinyl polymers with bile acid Adsorberwirkung
08/20/1998DE19705718A1 Neue Oxirancarbonsäuren zur Behandlung des Diabetes Typ 2 und anderer insulinresistenter Zustände New oxiranecarboxylic for the treatment of type 2 diabetes and other insulin-resistant states
08/20/1998DE19705450A1 Bicyclische aromatische Aminosäuren Bicyclic aromatic amino acids
08/20/1998CA2282683A1 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
08/20/1998CA2281795A1 The use of cyanines, isocyanines, and pseudoisocyanines as diuretics
08/20/1998CA2281690A1 Method for destroying retinal pigment epithelial cells
08/20/1998CA2281607A1 Pharmaceutical formulations in dry form for the oral administration of a cyclic quaternary ammonium compound
08/20/1998CA2281602A1 Cross-linked vinyl polymers with bile acid adsorbing effect
08/20/1998CA2281560A1 Pharmaceutical composition for oral administration of heterocyclic compounds in the form of quaternary ammonium
08/20/1998CA2281525A1 Biazacyclic crf antagonists
08/20/1998CA2281224A1 Treatment of infarcts through inhibition of nf-kappab
08/20/1998CA2281086A1 Oligomers which inhibit expression of collagen genes
08/20/1998CA2281000A1 Diagnosis and treatment of glaucoma
08/20/1998CA2280874A1 Bioreductive conjugate for targeting a therapeutic agent
08/20/1998CA2280871A1 Use of nitric oxide synthase inhibitors for the treatment of diabetes
08/20/1998CA2280857A1 Pharmaceutical formulations comprising amoxocyllin and clavulanate
08/20/1998CA2280776A1 Athletic endurance increasing agent in food
08/20/1998CA2280761A1 Benzimidazole derivatives
08/20/1998CA2280742A1 Method of using neurotrophic sulfonamide compounds
08/20/1998CA2280722A1 Compositions for the inhibition of bone resorption
08/20/1998CA2280209A1 Variants of vascular endothelial cell growth factor having altered pharmacological properties, and related aspects thereof
08/20/1998CA2279641A1 Remedies/preventives for respiratory diseases
08/20/1998CA2279590A1 Targeted therapeutic delivery of vitamin d compounds
08/20/1998CA2278757A1 5-aminoalkoxy-1,4-dihydroquinoxaline-2,3-diones being dopamine agonists
08/20/1998CA2278747A1 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-one derivatives, their preparation and their use as dopamine autoreceptor (d2) agonists
08/20/1998CA2278746A1 4-aminoethoxyindazole derivatives
08/20/1998CA2278718A1 4-aminoalkoxy-1,3-dihydrobenzoimidazol-2-thiones derivatives, their preparation and their use as dopamine autoreceptor (d2) agonists
08/20/1998CA2278700A1 4-aminoalkoxy-1h-benzimidazole derivatives, their preparation and their use as dopamine autoreceptor (d2) agonists
08/20/1998CA2278421A1 Drugs inhibiting progress of pterygium and postoperative recurrence of the same
08/20/1998CA2251580A1 Amides as npy5 receptor antagonists
08/20/1998CA2251368A1 Amide derivatives as selective neuropeptide y receptor antagonists
08/20/1998CA2243984A1 Neural cell adhesion molecule splicing variants
08/20/1998CA2229947A1 Sulfonamide-substituted chromans, processes for their preparation, their use as medicament or diagnostic aid, and medicament comprising them
08/19/1998EP0859058A2 Nucleic acid construct for expression of protease activatable substances
08/19/1998EP0859004A1 Piperidine derivatives having anxiolytic effect
08/19/1998EP0859000A1 Isoxazole amide and crotonamid derivatives and drug and diagnostic uses thereof
08/19/1998EP0858999A1 Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
08/19/1998EP0858807A2 Use of dopamine receptor antagonists in palliative tumor therapy
08/19/1998EP0858806A1 Use of a combination of beta-sitosterol and beta-sitosterol glucoside for treating HIV infection
08/19/1998EP0858805A2 Transdermal preparations of oxicams
08/19/1998EP0858804A1 Use of rifaximin in the treatment of the diarrhoea from cryptosporidiosis
08/19/1998EP0858803A1 Composition for local anesthesia
08/19/1998EP0858802A2 Pharmaceutical preparation of thioctic acid for oral administration
08/19/1998EP0858742A2 Nitrate-free powdered fruits or vegetables and manufacturing process therefor
08/19/1998EP0858508A1 Novel peptides useful in enhancement of fsh action
08/19/1998EP0858506A2 Genetic induction of receptors for targeted radiotherapy
08/19/1998EP0858504A1 Diagnostics and treatments of periodontal disease
08/19/1998EP0858503A1 METHODS FOR USE OF Mpl LIGANDS WITH PRIMITIVE HUMAN STEM CELLS
08/19/1998EP0858466A1 Use of protein gax for treating cancer
08/19/1998EP0858465A2 Anti-tumoral protein
08/19/1998EP0858464A1 Thrombin inhibitors
08/19/1998EP0858461A1 Fused tropane-derivatives as neurotransmitter reuptake inhibitors
08/19/1998EP0858459A1 Novel acid pyrazole derivatives, preparation method therefor, use thereof as drugs, novel use therefor, and pharmaceutical compositions containing such derivatives
08/19/1998EP0858458A1 Antithrombotic n-amidinopiperidine and benzamidine derivatives
08/19/1998EP0858457A1 5-membered heterocycles, pharmaceutical agents containing said compounds and the use thereof and methods of producing them
08/19/1998EP0858456A1 Triterpene derivatives with immunosuppressant activity
08/19/1998EP0858455A1 4-oxa and 4-thia steroids
08/19/1998EP0858453A1 5-(acetamidomethyl)-3-aryldihydrofuran-2-one and tetrahydrofuran-2-one derivatives with antibiotic activity
08/19/1998EP0858451A1 Pharmaceutically active quinazoline compounds
08/19/1998EP0858450A1 Quinolone compounds for the treatment of disorders caused by helicobacter pylori
08/19/1998EP0858445A1 New (3-alkoxy-phenoxy)-ethyl]-dialkylamine derivatives and their use as local anaesthetics
08/19/1998EP0858444A1 Cyclopentyl tachykinin receptor antagonists
08/19/1998EP0858443A1 4-phenyl-4-oxo-butanoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity
08/19/1998EP0858442A1 4-phenyl-4-oxo-2-butenoic acid derivatives with kynurenine-3-hydroxylase inhibiting activity
08/19/1998EP0858441A1 Triglycerides and ethyl esters of phenylalkanoic acid and phenylalkenoic acid useful in treatment of various disorders
08/19/1998EP0858346A1 Expression of cyclin g1 in tumors
08/19/1998EP0858344A2 Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis
08/19/1998EP0858343A1 Continuous low-dose cytokine infusion therapy
08/19/1998EP0858341A1 Combination therapy for advanced cancer comprising temozolomide and cisplatin
08/19/1998EP0858340A1 Combination therapy for the treatment of diabetes and obesity
08/19/1998EP0858339A1 A method of treating filariae
08/19/1998EP0858338A1 Pharmaceutical compositions of levo-enantiomers of medetomidine derivatives and their use
08/19/1998EP0858337A2 A pharmaceutical composition for the treatment of autoimmune diseases
08/19/1998EP0858336A1 Method and pharmaceutical composition for regulating lipid concentration
08/19/1998EP0858335A1 2-alkylpyrrolidines
08/19/1998EP0858334A1 Analgesic immediate and controlled release pharmaceutical composition
08/19/1998EP0858333A1 Thiamorphinans with neuroprotective activity
08/19/1998EP0858332A1 Triterpene derivatives with immunosuppressant activity
08/19/1998EP0858331A1 Spontaneously dispersible concentrates of sterol esters and vitamin d derivatives with antiviral, virucidal and/or parasiticidal effect
08/19/1998EP0858330A1 Compositions containing hydroperoxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders
08/19/1998EP0858329A1 Novel stable liquid paracetamol compositions, and method for preparing same
08/19/1998EP0858328A2 Stable compositions containing n-propargyl-1-aminoindan
1 ... 6618 6619 6620 6621 6622 6623 6624 6625 6626 6627 6628 6629 6630 6631 6632 6633 6634 6635 6636 6637 6638 ... 7860